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Abstract  18 
The Crown gall tumour assay (CGTA) is one of several bench top bioassays recommended 19 
for the rapid screening of plants with anti-cancer activity. The rationale for the use of the 20 
bioassay is that the tumorogenic mechanism initiated in plant tissues by Agrobacterium 21 
tumefaciens is in many ways similar to that of animals.  Several plant species with anti-cancer 22 
activity have already been discovered using this bioassay.  However till date no explicit test 23 
of an association between anti-cancer activity of plants and their resistance to crown gall 24 
formation has been demonstrated. Demonstration of an association could have exploratory 25 
potential when searching for plants with anti-cancer activity. In this paper, we determined 26 
whether or not a statistically significant association between crown gall resistance and anti-27 
cancer activity exists in plants found in existing published data sets.   Our results indicate 28 
that plants with anti-cancer activity have a higher proportion of their species resistant to 29 
crown gall formation compared to a random selection of plants. We discuss the implications 30 
of our results especially when prospecting for newer sources of anti-cancer activity in plants.  31 
 32 
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Introduction 42 
Bioprospecting for plants with anticancer activity has been a major focus in the search for 43 
plant-based cures [1]. The National Cancer Institute (NCI) alone has reportedly screened 44 
over 35,000 plant species for anti-cancer activity [2], [3], [4], [5], [6]. Two of the three most 45 
important anti-cancer compounds available today, namely taxol and camptothecin, were the 46 
result of this endeavor [7], [8],[9], [10].The screening of a large number of plants, involving 47 
over half-a-dozen solvent extraction systems, and testing them on dozens of cancer cell 48 
lines, has often been time-consuming [5]. 49 
 50 
In an effort to minimize the screening process and hasten the pace of drug discovery, the 51 
NCI developed a number of rapid bench top assays to short-list potential plants, which then 52 
could be targeted for more advanced screening [11]. One of those bench top bioassays was 53 
the crown gall tumour assay (CGTA) [12]. Crown gall is a neoplastic plant disease caused by 54 
Agrobacterium tumefaciens [13].  Infected plants, exhibit tumorgenic growth symptoms in stem 55 
collars and other parts of the plant. Crown gall is a common disease of dicot plants including 56 
many woody shrubs and various herbaceous plants. In this bioassay, the ability of plant 57 
extracts to inhibit tumours induced by A tumefaciens in model systems such as potato tuber 58 
discs is evaluated [14]. The rationale for employing this bioassay rests on the fact that the 59 
tumorogenic mechanism induced by A. tumefaciens in plants is in many ways similar to that of 60 
animals [15], [16]. The use of this bioassay has resulted in many short lists of plants with 61 
anti-cancer activity, and has helped with the discovery of novel compounds from plants [17], 62 
[18],  [14], [11], [19]. McLaughlin et al. (1991) indeed were able to show an association 63 
between the inhibition of crown gall formation on potato discs and the in vivo 3PS anti-64 
tumour activity by the plant extracts.   65 
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 66 
From the above results, it follows that  plants intrinsically resistant to crown gall infection 67 
could,  in principle at least also be associated with anti-cancer activity.  To the best of our 68 
knowledge, there have been no attempts to evaluate this hypothesis. A test of the prediction 69 
and demonstration of an association between crown gall resistance and anti-cancer activity 70 
could have immense exploratory potential in the search for newer plants as sources of anti-71 
cancer activity. We have examined the association between crown gall resistance and anti-72 
cancer activity in plants and now report on the results of that study. 73 
 74 
Materials and Methods 75 
We compiled a database of 1193 species (comprised of 588 genera and 138 families) of dicot 76 
plants based on their resistance or susceptibility to crown gall infection as reported in Cleene 77 
et al., (1976).  Species were assigned a qualitative score of either crown gall resistance (+) or 78 
susceptible (-). For the purpose of this analysis, we used data on only those 1110 species for 79 
which the information was complete.  80 
 81 
We then compiled a list of 38 plant species that were reported to possess anti-cancer activity 82 
from a variety of published sources (Plants for future Database, www.pfaf.org and other 83 
references mentioned in Table 1). All studies sourced here were based on either an in vitro or 84 
an in vivo assay for anti-cancer activity.   85 
 86 
Based on these two datasets, we analyzed the average proportion of species resistant to 87 
crown gall: Using a bootstrap analysis involving repeated sampling with replacement 88 
(PopTools version 2.6.2); [20], we randomly selected 100 species from the database and 89 
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determined the proportion of species resistant to crown gall. The process was repeated 100 90 
times. For each of the repeats, we computed the proportion of species resistant to crown 91 
gall. A frequency distribution of the proportion of species resistant to crown gall was then 92 
plotted and the overall mean proportion of species resistant along with the standard 93 
deviation was computed. The proportion of species resistant to crown gall from among the 94 
38 species reported to possess anti-cancer activity was calculated. For each of the 38 plants, 95 
we inferred their resistance or otherwise to crown gall from the database assembled from 96 
Cleene et al., (1976) and computed the proportion of species that were resistant. 97 
 98 
Finally,  we performed a test of significance between the two proportions (for species drawn 99 
randomly vs species possessing anti-cancer activity) using a one-tailed student t-test. 100 
 101 
Results and discussion 102 
The frequency distribution of proportion of species resistant to crown gall for the randomly 103 
drawn species (N=100 from 1110 species, repeated 100 times) was nearly normally 104 
distributed, with an overall mean proportion of 0.41±0.051 (Figure 1). The proportion of 105 
species resistant to crown gall among plants exhibiting anti-cancer activity (N=38) was 0.81, 106 
which was significantly higher than that of randomly selected plants (one tailed t-test, 107 
p<0.001).  108 
 109 
 110 
Plants with anti-cancer activity therefore appear to have a higher proportion of species 111 
resistant to crown gall than randomly selected species. While the result suggests that an 112 
association between crown gall resistance and anti-cancer activity in plants exists, a more 113 
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robust demonstration would have been to set up   a 2 X 2 matrix of crown gall 114 
(resistance/susceptibility) and anti-cancer activity (present/absent) and then statistically 115 
evaluating the association.  Demonstration of such an association may have more accurately 116 
shown if plants with anti-cancer activities are more likely to be found in plants that are 117 
resistant to crown gall compared with a randomly chosen set of species. Unfortunately, 118 
because of a well-recognized positive bias in publications, papers often only report studies 119 
where anti-cancer activity was observed, seldompublishing studies with no activity.  120 
Consequently, a 2 X 2 matrix with data cells corresponding to crown gall 121 
resistance/susceptibility and anti-cancer activity (absence) is deficient thus limiting the 122 
association analysis. 123 
 124 
Though not as directly demonstrative as would have been desired, our results nevertheless 125 
provide a useful first step in working towards a more robust test of the association.  Results 126 
of further analysis could pave the way for the development of algorithms that make the 127 
search for anti-cancer activity in plants in a more directed manner. 128 
 129 
 130 
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Figure and table legends  278 
Figure 1: Frequency distribution of proportion of species resistant to crown gall formation in 279 
randomly selected plants (see text for details).  The mean proportion of species resistant to 280 
crown gall for a random collection of plants and that for plants with anti-cancer activity is 281 
also indicated. 282 
Table 1:  List of plant species with anti-cancer activity along with information on crown gall 283 
resistance or susceptibility.   284 
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Figure 1: Frequency distribution of proportion of species resistant to crown gall formation in 328 
randomly selected plants (see text for details).  The mean proportion of species resistant to 329 
crown gall for a random collection of plants and that for plants with anti-cancer activity is 330 
also indicated. 331 
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Table 1:  List of plant species with anti-cancer activity along with information on crown gall resistance or susceptibility.   341 
 342 
Sl 
no Common name Scientific name Family Anti-cancer activity 
Crown gall 
resistance or 
suceptiblity 
(inferred from 
Cleene et al., 
1976) 
    Reference In vivo or in vitro anticancer assay  
1 Aster  Aster sp Compositae [21] Epifriedelinol shows anti-cancer activity Resistant 
2 Birch Betula alleghaniensis Betulaceae [22] Induces apoptosis in human melanoma and neuroblastoma cells Resistant 
3 Blueberry Vaccinium sps Ericaceae [23] Induces Phase-II Xenobiotic detoxification enzymes Resistant 
4 Cactus Opuntia microdasys Cactaceae [24] Induces apoptosis and cell cycle arrest of cancer cells. Resistant 
5 Dahlia Dahlia rosea Compositae [25]  Resistant 
6 Gossypium Gossypium Malvaceae [26] Cytotoxic to murine B16 melanoma and L1210 lymphona cells Resistant 
7 Hydrangea Hydrangea serrata Hydrangeaceae [25]  Resistant 
8 Maple  Acer sp  Sapindaceae [27] Possesses activity against Walker 256 and Sarcoma 180 cell lines Resistant 
9 Rhododendron Rhododendron indicum Ericaceae [28] Cytotoxic against Spodoptera frugiperda cell line Sf-9 Resistant 
10 Sequoia Sequoia sempervirens Taxodiaceae [29] Shows Brine Shrimp Lethality Resistant 
11 Spruce Picea sps Pinaceae [30] Inhibits growth of LNCaP tumors in Mice. Resistant 
12 Maidenhair tree Ginkgo biloba Ginkgoaceae [31] Inhibits DNA damage Resistant 
13 
Golden-rain 
tree  Koelreuteria paniculata  Sapindaceae [32] Tyrosine kinase inhibition Resistant 
14 Holly Ilex aquifolium Aquifoliaceae [33] 
Ursolic Acid Inhibits Cyclooxygenase-2 Transcription in Human 
Mammary Epithelial Cells Resistant 
15 Hornbeam Carpinus betulus Betulaceae [34] Active against human melanoma cells Resistant 
16 Serviceberry Amelanchier spp. Rosaceae [35] Berry extract induces cell-cycle arrest. Resistant 
17 Barberry Berberis vulgaris Berberidaceae [36] 
Berberine affects the structure of filamentous actin cytoskeleton 
of the B16 cells. Resistant 
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18 Mahonia Mahonia fremontii Berberidaceae [37] 
Protoberberine shows antimutagenic activity by 
inhibiting Topoisomerase I Resistant 
19 Linden Viburnum dilatatum Caprifoliaceae [38] 
Iridoids glucosides exhibits moderate inhibitory activity 
against HeLa S3 cancer cells Resistant 
20 Larch Larix decidua Pinaceae [39] LaPSvS1 showed good antiangiogenic activity in CAM-assay. Resistant 
21 Magnolia   Magnoliaceae [28] Induces apoptosis in lukemia cells Resistant 
22 Pine  Pinus sp Pinaceae [7] Cell cycle arrest: inhibits tubulin diassembly Resistant 
23 Douglas fir Pseudotsuga menziesii Pinaceae [40] Induces growth inhibition in human lung carcinoma cells Resistant 
24 Bald Cypress Taxodium distichum. Cupressaceae [41] Cell cycle arrest: inhibits tubulin diassembly Resistant 
25 Hemlock Conium maculatum Umbelliferae [42] Inhibits malignant tumours especially breast cancer. Resistant 
26 Redbud Cercis canadensis Redbud [42], [25] Antilukemia Resistant 
27 Smoke tree Cotinus coggygria Anacardiaceae [43] 
Gallic acid has been shown to display selective cytotoxicity 
against tumor cells, and to induce apoptosis in tumor cells. Resistant 
28 Yew Taxus baccata Taxaceae [7] Cell cycle arrest: inhibits tubulin diassembly Resistant 
29 Andromeda  Andromeda sp Ericaceae [25]  Resistant 
30 Mimosa Albizia julibrissin Leguminosae [24] Shows marked inhibitory action against Bel-7402 Cancer cell line. Resistant 
31 Mountain laurel Kalmia latifolia Ericaceae [44] Shows cytotoxicity against 9KB cell lines Resistant 
32 Euonymus Euonymus alatus apterus Celastraceae [21] Dulcitol inhibits growth of cancerous cells Suceptible 
33 Rose Rosa roxburghii Rosaceae [45]  Suceptible 
34 Russian- olive Elaeagnus angustifolia Elaeagnaceae [46] Inhibits several stages in colon carcinogenesis. Suceptible 
35 Almond Prunus dulcis Rosaceae [47] 
Betulinic acid showed antiproliferative activity toward MCF-7 
cells (GI50 = 0.27µM) Suceptible 
36 Walnut Juglans sps Juglandaceae 
 
 
Plumbagin is a potent inhibitor of the NF-B activation. 
 Suceptible 
37 Ficus Ficus citrifolia Moraceae [48]  Suceptible 
38 Wisteria Wisteria sinensis Fabaceae [25]  Suceptible 
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